LEVI
Levi Strauss & Co.
LEVI's fundamentals are mixed: free cash flow about doubled, but earnings per share fell 2%. At 16x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
LEVI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
LEVI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LEVI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $18.30 | -24% |
| Forward | 15x | $24.04 | — |
| Fair | 16x | $23.57 | -1.9% |
| Current | 16x | $24.04 | — |
| Expensive | 38x | $55.97 | +133% |
Historical ranges are pointers, not guarantees.
LEVI's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
LEVI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LEVI, with profitability improving.
LEVI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.57 | +5.2% |
| Q3 2026 | $1.49 | -2% |
| Q2 2026 | $1.61 | +58% |
| Q1 2026 | $1.56 | +75% |
| Q4 2025 | $1.45 | +179% |
| Q3 2025 | $1.52 | +311% |
| Q2 2025 | $1.02 | +200% |
| Q1 2025 | $0.89 | +197% |
| Q4 2024 | $0.52 | -16% |
LEVI earned $1.49 per share over the past year, down 2% from the year before.
LEVI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +4.3% |
| Q2 2026 | $1.6B | +8% |
| Q1 2026 | $1.7B | +14% |
| Q4 2025 | $1.8B | -4% |
| Q3 2025 | $1.5B | +1.8% |
| Q2 2025 | $1.4B | +0.3% |
| Q1 2025 | $1.5B | -2% |
| Q4 2024 | $1.8B | +12% |
LEVI's revenue has picked up after three years of holding roughly level: $1.6B last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +3 points |
| Q2 2026 | 7.8% | +0.4 points |
| Q1 2026 | 11% | -1.2 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 11% | +8.8 points |
| Q2 2025 | 7.5% | +5.9 points |
| Q1 2025 | 13% | +13 points |
| Q4 2024 | 12% | +2.3 points |
LEVI's operating margin was 14% last quarter, up 3 points from the same quarter a year ago.
LEVI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | +$83.7M |
| Q2 2026 | $230.9M | +58% |
| Q1 2026 | $152.1M | +$166.2M |
| Q4 2025 | $215.7M | -6.9% |
| Q3 2025 | -$39.4M | -1813% |
| Q2 2025 | $146M | -34% |
| Q1 2025 | -$14.1M | -107% |
| Q4 2024 | $231.6M | +14% |
LEVI generated $643M in free cash flow over the past year, up 98% from the year before.
LEVI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +991K shares |
| 1 year | -2.2% | -8.9M shares |
| 3 years | -2.6% | -10.4M shares |
| 5 years | -5.4% | -22.5M shares |
| Available history | -5.2% | -21.4M shares |
LEVI has 391M diluted shares, down 2.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $500,000 |
| Q1 2025 | $30M |
| Q4 2024 | $30.4M |
LEVI hasn't bought back shares in the past year.
LEVI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.7x | Very low |
LEVI's net debt is less than a year of its operating earnings (EBITDA).
LEVI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.3 | Neutral |
| Stochastic | 71.3 | Neutral |
LEVI's weekly RSI is 61 (neutral) and its Stochastic is 71 (neutral).
LEVI PE vs Consumer Cyclical Sector
| Metric | LEVI | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 50 | 47 | 3 pts above |
LEVI is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
LEVI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 14% above |
| 20 week MA | $22.1 | 8.7% above |
| 50 week MA | $21.8 | 10% above |
| 100 week MA | $20.3 | 18% above |
| 200 week MA | $18.7 | 29% above |
LEVI is in an uptrend: it's above all five of its weekly moving averages, and 29% above its 200-week average.
LEVI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.3 | $20.6 | +7.1% |
| 2021 | $20.6 | $24.6 | +19% |
| 2022 | $24.6 | $15.5 | -37% |
| 2023 | $15.5 | $16.5 | +6.8% |
| 2024 | $16.5 | $17.2 | +3.9% |
| 2025 | $17.2 | $21.1 | +23% |
| 2026 YTD | $21.1 | $24.0 | +14% |
LEVI has finished higher in five of the last six years. It's up 14% so far in 2026.